Company ProfilePremium

Atlas Pearls Ltd

Company Profile Analysis

Ticker: ATP.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Atlas Pearls Ltd - Company showcase

Year Founded & Workforce

1987

1,200 Employees

Atlas Pearls Ltd logo

Atlas Pearls Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Atlas Pearls Ltd Overview

Atlas Pearls is a vertically integrated, Indonesia-based producer of white and silver South Sea pearls cultivated in the gold-lip/silver-lip Pinctada maxima oyster, and one of the very few publicly listed pure-play pearl producers globally. It controls the full biological value chain — broodstock genetics, hatcheries, nurseries, nucleation (seeding), multi-year grow-out across eight farm locations and harvesting — and monetises output primarily through its own regular auctions in Kobe, Japan, supplemented by private wholesale sales, value-add programmes and a small retail/online channel. Annual harvests have been remarkably stable at roughly 600,000–630,000 pearls, so earnings are driven overwhelmingly by realised price per pearl, which is a function of quality mix and luxury-goods demand in Japan, Hong Kong and mainland China. After a record FY2024 (NPAT A$31.5m) on cyclical price highs, FY2026 delivered a statutory loss as pearl quality and prices fell, testing management's FY30 roadmap to lift production 30–50%.


What the company does

Atlas Pearls produces South Sea pearls. In its own words (FY2026 Annual Report, Directors' Report §3), the Company produces South Sea pearls with pearling operations throughout Indonesia and sells them through a multi-channel distribution network; it describes itself as one of the world's largest producers and distributors of white and silver South Sea pearls, operating eight farming locations in Indonesia, employing more than 1,200 people, and harvesting 619,598 pearls in FY2026 (FY2025: 621,458). The stated vision is to be the global leader in producing the world's finest South Sea pearls; the mission emphasises sustainable, respectful production that cares for environment, people, communities and shareholders.

Production model (the biological value chain)

The pearl production cycle is long and capital-tied. Atlas's process, as described across the FY2025 and FY2026 annual reports, runs as follows:

  1. Broodstock and genetics — selective breeding through a "breeding matrix" programme intended to raise inherent pearl quality (lustre, size, colour, surface).

  2. Hatchery — spat (larval oysters) produced at Company hatcheries (North Bali, Lembata, West Lembata), now supported by probiotic-assisted processes.

  3. Nursery — juvenile oysters raised for roughly two years until large enough to nucleate. Since FY2025 a growing share of nursery activity has been outsourced to joint-venture nursery partners who grow Atlas-genetics spat on Atlas's behalf (capital-light, geographically diversified).

  4. Nucleation (seeding) — technicians implant a nucleus and mantle tissue; FY2026 saw a record number of oysters seeded. Oysters that reject the nucleus were historically sold cheaply; from FY2026 these are selectively re-seeded.

  5. Grow-out — nucleated oysters cultured at grow-out farms (notably Alyui Bay in West Papua and Alor), traditionally for 24 months post-seeding; Alyui is moving ~80% of production to an 18-month cycle in FY2027, Alor ~20%.

  6. Harvest and grading — pearls harvested, graded using an internal Quality Index Score / Index Point system (shape, grade, size, colour), and allocated to channels.

  7. Sale — Kobe auctions (roughly quarterly), private wholesale appointments, value-add wholesale (strands, matched sets), retail showrooms/online, and by-product sales (mother-of-pearl shell, oyster meat, low-grade/reject pearls).

A new purpose-built logistics and harvesting vessel, the Atlas Pearl, was undergoing sea trials at the time of the FY2026 report and was scheduled to sail to North Bali in September 2026, with its first pearl harvest planned for October 2026.

Revenue model

Revenue typeDescriptionDisclosure
Product sales — loose pearls (auction)Kobe auctions, roughly 4 per year, sold to international wholesalersMajority of revenue; average auction price FY2026 A$63/pearl vs A$87 in FY2025 (FY2026 AR)
Product sales — loose pearls (private)Private appointments with wholesale customersMaterial and growing; e.g. ~A$1.35m sold privately in Apr–May 2026 (June 2026 auction update)
Product sales — value-add and retailStrands, jewellery, farm showrooms, Bali retail, onlineSmall; not separately quantified in FY2026
By-productsShell, low-grade/reject pearls, otherFY2026 by-product cash receipts A$1.18m (cash flow statement)
Services / subscription / licensing—Not applicable

All revenue is recognised at a point in time as sale of goods (FY2026 AR, Note 3). The business is therefore 100% product revenue, with no recurring contracted revenue.

Customer types and end-markets

Customers are predominantly international pearl wholesalers and jewellery manufacturers attending the Kobe auctions — historically Japanese, Hong Kong and mainland Chinese buyers — plus private wholesale clients and a small number of retail consumers. Concentration has been significant: in FY2025 one customer accounted for A$14.3m of revenue (~32%), attributed to the Australian segment; in FY2026 no single customer exceeded 10% of revenue (FY2026 AR, Note 2.1). End-demand is the global luxury jewellery market, with China/Hong Kong and Japan the dominant consumption and trading hubs.

Independent characterisation

Atlas is best understood as an aquaculture commodity producer with luxury-goods price exposure: volume is quasi-fixed in the short term (two-to-four-year biological lead times), costs are largely fixed (labour, vessels, remote sites), and price per pearl swings sharply with both harvest quality and Asian luxury sentiment. This produces extreme operating leverage — revenue rose 53% in FY2024 while NPAT rose 246%; revenue fell 42% in FY2026 and the Company swung to a A$7.9m loss. Reported earnings are further amplified by AASB 141 Agriculture fair-value revaluation of oysters, which added A$13.9m in FY2024 and subtracted A$7.9m in FY2026.

Strategy

Stated strategy

The FY30 Strategic Roadmap (introduced with FY2025 results, refined in FY2026, and now being extended to FY32) rests on four pillars: (1) Quality Operations; (2) Innovation; (3) People & Culture; (4) Customers & Stakeholders. Management's overarching objective is to grow pearl production, improve quality and reduce the real cost of production through operational excellence, scale and innovation. Under Quality Operations, initiatives are consolidated into three business-wide programmes: the Pearl Improvement Plan, the Revised Operating Model, and Revenue Diversification Opportunities.

Medium-term targets

Target / guidanceDetailSource
Production capacity+30% to +50% by FY2030FY2025 4E / AR
Alyui site outputFrom ~180k to >400k pearls p.a. over medium-to-long term (expansion plus 18-month cycle)FY2026 AR
Throughput uplift from 18-month cycle~25% long-term increase at sites adopting it, at optimal stockingFY2026 AR
Re-seeding programmeA$1.0–1.5m additional annual earnings from FY2029FY2026 AR
Dividend policyTarget payout of 50% of normalised NPATFY2024/FY2025 reporting
Formal revenue/earnings guidanceNone provided—

Initiative register (last 24 months)

InitiativeTimingScope and status
JV nursery partner networkFY2025–ongoingLong-term JV partners grow Atlas-genetics spat; expanded in FY2026; Company has mapped best-performing nursery locations to guide future own-nursery decisions
Organic capacity expansionFY2026Alor +50k, Alyui +25k nucleated; West Lembata +30k and Pungu +50k nucleated-equivalent spat capacity
Alyui lease expansionApproval FY2026; build from H2 FY20277 blocks approved, 5 progressing
Cultivation-cycle optimisationFY202718-month cycle at ~80% of Alyui and ~20% of Alor
Genetics and hatchery programmeOngoingBreeding matrix; probiotic-supported hatchery; first benefits appearing in early FY2027 harvests
North Bali mortality responseH2 FY2026Hatchery output redirected; oyster transfers into North Bali suspended; environmental monitoring expanded to all sites
Re-seeding of rejected oystersFY2026Selectively reintroduced
Atlas Pearl logistics vesselCommissioning Sep–Oct 2026Optimises shell transfers and harvesting logistics
Site portfolio optimisationFY2026Sumba mothballed; ~20 greenfield sites in pipeline
Sales strategyFY2024–ongoingMulti-channel model to reduce auction and customer concentration; data-driven pricing; redirecting suitable inventory to value-add and retail
Lobster aquaculture pilotFY2027Grow-out trial to test commercial viability for export to Asian markets
Multi-species hatchery licensingFY2026Government licensing approvals received
Government & Stakeholder Engagement PlanFY2026Formal framework aligned with Indonesia's Blue Economy Roadmap 2023–2045
LeadershipFY2026Dedicated COO role created (Mat Pullen)
HSEFY2026–ongoingProgress toward ISO 45001; Just Culture framework; ICAM investigations
Sustainability FrameworkFY2026Three pillars, 13 pathways, six KPIs; GRI-aligned FY2026 Sustainability Report
Cost programme—No quantified cost-reduction programme with targets disclosed

Products & Services

Atlas is a single-product-family business; the catalogue below is organised by product category and channel rather than by segment, because both segments sell the same products.

Launch/version years: the loose-pearl business has operated since the 1990s; Kobe auction channel since May 2012; Employee-facing retail showrooms reopened progressively from FY2023–FY2024 after the pandemic; re-seeding reintroduced FY2026; lobster pilot FY2027. No flagship branded sub-lines with separate disclosure exist.

Product Portfolio

Product / offeringDescriptionKey specificationsTarget customerChannelPricing disclosure

White South Sea loose pearls (first-operation)

Core product cultivated in Pinctada maxima

Historically focused on 10–14mm diameter (per former MD); graded by shape, surface, lustre, size and colour via internal Index Point system

International wholesalers, jewellery manufacturers

Kobe auctions; private appointments

Auction averages: Sep 2025 A$60; Dec 2025 A$80; Mar 2026 A$66; Jun 2026 A$55; Sep 2026 A$75.90 per pearl

Silver South Sea loose pearls

Silver-toned variant from the same species

As above

As above

As above

—

Re-seeded (second-operation) pearls

New from FY2026: oysters that rejected their first nucleus are re-seeded rather than sold off

Typically lower quality than first-operation pearls

Wholesale

Auction/private

Management estimate: A$1.0–1.5m additional annual earnings from FY2029

Low-grade, C2 and reject pearls

Lower-quality output

Below commercial auction grades

Bulk wholesale, Indonesian buyers

Private/bulk

FY2026: 273k pearls sold at average A$3.45 (FY2025: 149k at A$6.90)

Keshi pearls

Non-nucleated pearls formed as by-product

Irregular shapes

Wholesale and jewellery

Wholesale; jewellery (e.g. keshi studs)

—

Value-add wholesale programmes

Strands, matched pairs, curated lots

Matched size/colour sets

Wholesalers, retailers

Private wholesale

Not disclosed; management prioritising redirection of suitable inventory into this channel

Atlas Pearls jewellery

Pearl jewellery designed/manufactured in-house (examples historically marketed include pendants, studs, rings, bracelets — e.g. cage pendant, keshi studs, vine ring, double pearl bracelet, paved diamond pendant)

Silver/gold settings with South Sea and keshi pearls

Retail consumers, tourists

Bali retail, farm showrooms (e.g. Pungu, reopened FY2024), online store

Retail list prices not disclosed in filings

Mother-of-pearl shell and by-products

Shell and other oyster by-products

—

Industrial/craft buyers

Indonesia

FY2026 cash receipts A$1.18m; FY2025 A$1.52m

Lobster aquaculture (pilot)

Pilot grow-out of spiny lobster from Indonesian wild-caught seed (puerulus) for export to Asian markets

Trial covers husbandry, feed formulation, feed conversion and growth

Asian seafood markets

Not yet commercial

Pilot commenced FY2027; business case pending

Multi-species hatchery

Licensing approvals received for multi-species hatchery and farming

———

Pre-commercial

“—” = not publicly disclosed.

Financial Narrative

Income statement

Sources: FY2026 AR §5.1, §14.2.2 and financial statements; FY2024 AR; FY2023 AR; FY2026 AR revenue/EBITDA chart for FY2022–FY2023 revenue and EBITDA; S&P Global (StockAnalysis) for FY2022–FY2023 PBT/tax and gross profit. Discrepancies: (i) FY2022 revenue is A$20.6m in the FY2026 AR chart but A$21.51m in S&P data (likely inclusion of other income); (ii) FY2025 PBT is A$26.97m audited vs A$27.31m in S&P data; (iii) FY2025 NPAT was headlined as A$21.9m in the FY2025 Appendix 4E and media, but the audited income statement (reproduced as FY2026 comparatives) shows A$21.57m — the A$21.90m figure equals NPAT plus A$0.33m actuarial gains recognised in other comprehensive income; (iv) the FY2025 announcement described FY2024 dividends as 1.85c, which is the cash-paid figure, while the declared-for-year figure was 2.5c (1.5c March 2024 + 1.0c September 2024).

Margins and growth

Derived revenue CAGR: FY2022–FY2025 ≈ 29.0% p.a.; FY2022–FY2026 ≈ 5.8% p.a. (derived).

Commentary. The five-year profile is a full price cycle in miniature. FY2022–FY2024 margins expanded dramatically because pearl prices roughly doubled (record A$103/pearl in H1 FY2024) against a largely fixed farm cost base, and because rising oyster valuations produced large non-cash AASB 141 gains (A$13.9m in FY2024 alone, explaining why pre-tax margin approached 95%). FY2025 revenue held up (+6%) only because volume sold rose 24% to 593k pearls while price normalised (H1 FY2025 average A$65 vs A$103 a year earlier); normalised EBITDA fell 18%. FY2026 then combined three negatives: (1) quality index down 18% (15% excluding the Sumba trial site); (2) softer luxury demand and FX headwinds, cutting the auction average to A$63 from A$87; and (3) a mix shift to low-grade pearls (273k units at A$3.45). The swing in the biological revaluation from +A$5.9m to −A$7.9m and a A$2.6m impairment (Note 11, loans receivable) turned a still-positive normalised EBITDA of A$5.8m into a A$7.9m statutory loss. The Chairman notes non-cash losses of A$11.9m in FY2026 versus non-cash net gains of A$4.1m in FY2025.

Normalised EBITDA reconciliation (company-reported)

Source: FY2026 AR §5.1. Normalised EBITDA is non-IFRS and unaudited.

FY2026 operating cost base

Administration, finance and marketing combined fell A$0.9m to A$8.0m (FY2026 AR §5.2.1), showing modest cost discipline but far less flex than the A$18.5m revenue decline. FY2025 other income was inflated by a A$1.95m FX gain.

Balance sheet

Sources: FY2026 AR statements and §5.2; S&P Global for FY2022–FY2023 (and FY2024 sub-lines). S&P classifies non-current biological assets within PP&E, so FY2022–FY2024 biological and PP&E splits are not shown. FY2025 biological assets were also summarised in secondary coverage as A$42.77m versus A$43.01m in audited statements (small variance, possibly a classification of a sub-line).

Commentary. The balance sheet is conservatively financed: effectively no financial debt since FY2023 (after retiring the Boneyard facility), an undrawn A$2.5m overdraft, and equity funding 84% of assets in FY2026. The quality of assets, however, is dominated by biological assets (A$37.0m, 58% of total assets at 30 Jun 2026) whose carrying value is a Level-3 fair-value estimate sensitive to assumed future pearl prices, quality and mortality — the primary source of earnings volatility. Cash fell A$13.3m in FY2026 as operating cash flow went to roughly zero while the Company sustained capex (A$4.4m PP&E, A$0.65m intangibles), dividends (A$6.1m) and a further A$1.2m loan to PT Cahaya Bali. Equity fell A$17.1m, driven by the loss, dividends and a A$3.4m adverse FX translation (weaker Indonesian rupiah).

Cash flow

FY2022 FCF from S&P Global; other years from audited cash flow statements (FY2024 AR; FY2026 AR). Commentary: FY2026's near-zero operating cash flow was depressed by A$5.4m of income tax paid — largely tax on the strong FY2025 result — while receipts from pearl sales fell to A$24.3m from A$43.2m. On a pre-tax basis, operating cash generation was ~A$5.3m, broadly consistent with normalised EBITDA. A current tax asset of A$1.57m at 30 Jun 2026 suggests some tax refund support in FY2027.

Ratios

ROIC is not presented: with negligible debt and earnings dominated by fair-value adjustments, a conventional ROIC calculation would largely duplicate ROE and would not be meaningful. Cash conversion cycle is not meaningful for a biological-asset business with a two-to-four-year production cycle; inventory of graded pearls (A$3.8m) plus biological assets (A$37.0m) relative to farm costs (A$11.6m) implies capital is tied up for roughly three years of farm spend.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment external revenue (AUD Mn)

Segment external revenue (AUD Mn)FY2024FY2025FY2026

Australia

—39.7720.60

Indonesia

—4.515.18

Total revenue from contracts with customers

41.7144.2725.78

Segment gross revenue incl. inter-segment (AUD Mn)

Segment gross revenue incl. inter-segment (AUD Mn)FY2025FY2026

Australia total segment revenue

39.7720.60

Indonesia total segment revenue

24.9920.82

Inter-segment eliminations

-20.49-15.64

Segment normalised EBITDA (AUD Mn)

Segment normalised EBITDA (AUD Mn)FY2024FY2025FY2026

Australia

—16.323.82

Indonesia

—2.281.95

Group normalised EBITDA

22.6318.605.77

Segment adjusted net operating profit before tax (AUD Mn)

Segment adjusted net operating profit before tax (AUD Mn)FY2025FY2026

Australia

15.694.78

Indonesia

2.83-12.68

Revenue by Segment (%) and Segment Margins & Growth (%)

Derived metric (%)FY2025FY2026

Australia share of external revenue

89.879.9

Indonesia share of external revenue

10.220.1

Australia YoY external revenue growth

—-48.2

Indonesia YoY external revenue growth

—15.0

Australia EBITDA margin on external revenue

41.018.5

Indonesia EBITDA margin on external revenue

50.637.7

Income statement (AUD Mn)

Income statement (AUD Mn)FY2022FY2023FY2024FY2025FY2026

Revenue from contracts with customers

20.627.241.7144.2725.78

Gross profit (S&P Global basis)

9.9416.333.4628.92—

Revenue less farm costs and inventory changes (company P&L basis)

———30.4514.19

Normalised EBITDA (company non-IFRS)

4.39.822.6318.605.77

Depreciation and amortisation

——0.320.440.45

Biological asset fair-value change (AASB 141)

——13.955.89-7.91

Impairment expense

——002.59

Profit before tax

5.439.7139.8126.97-7.90

Income tax expense

0.840.638.345.410.00

Net profit after tax

4.599.0931.4721.57-7.90

EPS basic (A$ cents)

1.082.147.374.93-1.80

EPS diluted (A$ cents)

———4.89-1.80

Dividends declared per share for the year (A$ cents)

00.352.52.40.45

Dividends paid per share in the year (A$ cents)

001.852.001.40

Margin / growth (%)

Margin / growth (%)FY2022FY2023FY2024FY2025FY2026

Revenue growth YoY

—32.053.36.1-41.8

Gross margin (S&P basis)

48.359.980.265.3—

Normalised EBITDA margin

20.936.054.342.022.4

Pre-tax margin

26.435.795.460.9-30.6

Net margin

22.333.475.548.7-30.6

Income Statement

Reconciliation item (AUD Mn)FY2024FY2025FY2026

Net profit after tax

31.4721.57-7.90

Interest (income)/expense

-0.26-0.37-0.20

Tax expense

8.345.410.00

Depreciation and amortisation

0.320.440.45

(Profit)/loss on disposal of assets

0-0.330.01

Net FX (gain)/loss

0.16-1.951.29

Agriculture standard revaluation (gain)/loss

-13.95-5.897.91

Changes in inventory (farm costs) (gain)/loss

-3.45-2.040.16

Write-down of pearls to net realisable value

01.531.45

Loss on deconsolidation

00.230

Impairment expense

002.59

Normalised EBITDA

22.6318.605.77

Operating cost line (AUD Mn)

Operating cost line (AUD Mn)FY2025FY2026

Farm costs and changes in inventory

13.8211.59

Administration expenses

8.357.51

Marketing expenses

0.520.43

Other expenses

1.412.53

Finance costs

0.060.03

Other income

2.730.37

Balance Sheet and Per-Share Data

Balance sheet (AUD Mn, 30 June)FY2022FY2023FY2024FY2025FY2026

Total assets

31.5240.0769.8585.8964.02

Cash and cash equivalents

3.007.8517.6220.216.95

Inventories

3.173.328.976.423.80

Biological assets current

———18.4515.95

Biological assets non-current

———24.5621.07

Property plant and equipment

———7.877.34

Loans receivable (non-current)

———3.851.81

Borrowings short-term

1.130000.04

Borrowings long-term

00000

Lease liabilities total

0.280.220.290.400.14

Net cash (cash less borrowings and leases)

1.597.6317.3319.816.77

Total liabilities

7.145.9814.3414.8510.06

Shareholders' equity

24.3734.0855.5271.0453.95

Goodwill

00000

Intangibles

0.02000.861.30

Working capital (current assets less current liabilities)

11.0416.4733.6539.6727.18

NTA per share (A$ cents)

——12.816.012.0

Shares on issue (millions)

424.8424.8433.6439.0439.0

Cash flow (AUD Mn)

Cash flow (AUD Mn)FY2022FY2023FY2024FY2025FY2026

Operating cash flow

—8.4520.6616.44-0.09

Capex — property plant and equipment

—2.161.853.234.45

Capex — intangibles

—000.910.65

Free cash flow (OCF less PP&E capex)

3.386.2918.8113.21-4.53

Loans advanced to PT Cahaya Bali

———1.821.20

Dividends paid

008.008.786.15

Share buybacks

00000

Income tax paid

—0.770.455.575.42

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (% NPAT / average equity, derived)

21.431.170.234.1-12.6

ROA (% NPAT / average assets, derived)

15.425.457.327.7-10.5

Current ratio (x)

3.165.205.356.668.17

Debt to equity incl. leases (x)

0.060.010.010.010.00

Net debt to EBITDA (x, negative = net cash)

-0.37-0.78-0.77-1.07-1.17

Asset turnover (x revenue / average assets, derived)

0.690.760.760.570.34

Normalised EBITDA interest coverage (x)

———326171

Revenue by location of sale (AUD Mn)

Revenue by location of sale (AUD Mn)FY2025FY2026

Australia (international loose-pearl sales booked in Australia)

39.7720.60

Indonesia (local sales and by-products)

4.515.18

Growth by location of sale (%)

Growth by location of sale (%)FY2026

Australia YoY

-48.2

Indonesia YoY

15.0

Non-current assets excl. financial instruments and DTA (AUD Mn)

Non-current assets excl. financial instruments and DTA (AUD Mn)FY2025FY2026

Australia

0.130.06

Indonesia

34.3432.33

Share price metric

Share price metricFY2022FY2023FY2024FY2025FY2026

Fiscal-year share price change (%)

1401711776-50

Share price at 30 June (A$ cents)

——9.116.58.3

Valuation Multiple Details

Valuation multipleAtlas PearlsListed peer set

Market capitalisation

~A$40m

No directly comparable listed peers

Enterprise value (market cap less net cash A$6.8m)

~A$33m

—

P/E (FY2026)

Not meaningful (loss)

—

P/E (FY2025 EPS 4.93c)

~1.8x

—

EV / normalised EBITDA (FY2026)

~5.8x

—

EV / normalised EBITDA (FY2025)

~1.8x

—

EV / Sales (FY2026)

~1.3x

—

P / Book (FY2026 equity A$53.95m)

~0.74x

—

P / NTA (12.0c)

~0.76x

—

Dividend yield (0.45c FY2026 final)

~4.9%

—

Dividend (A$ cents)

Dividend (A$ cents)Ex/payment timingAmountFranking

FY2023 final

Ex 4 Sep 2023 / paid 26 Sep 2023

0.35100%

FY2024 interim/special

Ex 7 Mar 2024 / paid 22 Mar 2024

1.5037.33%

FY2024 final/special

Ex 12 Sep 2024 / paid 27 Sep 2024

1.00100%

FY2025 interim + special

Ex 6 Mar 2025 / paid 21 Mar 2025

1.00 (0.61 interim + 0.39 special)

0%

FY2025 final

Ex 4 Sep 2025 / paid 26 Sep 2025

1.40100%

FY2026 interim

—0—

FY2026 final

Record 1 Sep 2026 / paid 25 Sep 2026

0.45100%

Dividends declared per share by fiscal year (A$ cents)

FY2022

FY2023

FY2024

Total declared

00.352.5

Analyst Conclusions

Management guidance

No quantitative revenue or earnings guidance is given. Qualitative outlook (FY2026 AR): management enters FY2027 citing record seeding, expanded oyster supply channels, increased farm capacity and encouraging early-harvest quality, while acknowledging ongoing market uncertainty. Structural targets remain +30–50% production capacity by FY2030 and Alyui output >400k pearls p.a. in the medium-to-long term. Closing pearl inventory of 159k (vs 219k a year earlier) means FY2027 sales depend more heavily on in-year harvests.

Consensus

No sell-side coverage; consensus growth expectations not available.

Bull case

  1. Quality inflection plus operating leverage: if early FY2027 quality gains (~20% above post-2022 average at Alor and Pungu) spread across the harvest, realised prices could recover toward the A$80+ auction levels seen as recently as December 2025, and FY2024 demonstrated that modest price gains translate into outsized EBITDA growth on a fixed cost base.

  2. Volume growth is low-cost and visible: Alyui block approvals, 18-month cycles at the two farms producing ~two-thirds of output, record FY2026 seeding and re-seeding could lift harvests materially by FY2028–FY2030 without new equity.

  3. Deep value with a clean balance sheet: at ~0.74x book and ~5.8x trough EV/EBITDA, with no debt and a still-positive dividend, the market price implies little recovery is expected.

Bear case

  1. Structural price deterioration: value per index point has fallen ~37% from A$4.08 (Jun 2025) to A$2.56 (Sep 2026); if Chinese luxury demand and freshwater substitution keep pressure on South Sea pricing, quality gains may not restore revenue.

  2. Biological supply risk: unresolved North Bali mortality, the Sumba failure and reliance on third-party JV nurseries could create a production gap in FY2028–FY2029, undermining the FY30 target.

  3. Shrinking financial buffer and governance questions: cash fell to A$6.9m; operating cash flow was nil; the Company continues to fund a deconsolidated affiliate that required a A$2.6m impairment; discretionary bonuses in a loss year and an ASX disclosure query weigh on governance perception.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
November 2026 Kobe auctionNov 2026Average price, index score, $/index point (vs A$2.56), sell-through
2026 AGMLate 2026Remuneration vote given discretionary bonuses; board renewal
Atlas Pearl vessel first harvestOct 2026Operational efficiency, shell-transfer cost savings
H1 FY2027 resultsLate Feb 2027Revenue recovery, return to statutory profit, interim dividend, cash balance
Quarterly Kobe auctionsMar/Jun 2027Sustained quality improvement across sites
Alyui block expansionH2 FY2027Commencement of 2–4 new blocks
North Bali environmental findingsFY2027Root-cause identification; resumption of transfers
Lobster pilotFY2027Growth and feed-conversion data; business case
APA extensionFY2027Tax certainty on transfer pricing
PT Cahaya Bali exposureOngoingFurther advances or impairments

Analyst verdict

Atlas Pearls is a genuinely distinctive listed asset — a vertically integrated, debt-free producer of roughly 620,000 South Sea pearls a year with thirty years of operating know-how in Indonesia — but it is also a textbook cyclical whose reported profits overstate stability on the way up and understate it on the way down. The five-year record is a complete price cycle: normalised EBITDA rose from A$4.3m (FY2022) to A$22.6m (FY2024) on record prices and then fell back to A$5.8m (FY2026) as quality slipped, buyers retreated and the grade mix deteriorated. Volume barely moved throughout; price and quality did all the work.

The investment question for the next two years is therefore narrow: can management restore quality and grow volume faster than the market erodes value per quality point? The evidence is mixed. On the positive side, record seeding, approved Alyui expansion, shorter cultivation cycles and early FY2027 quality readings around 20% above the recent average are concrete, low-capital levers, and the balance sheet, though thinner, carries no debt. On the negative side, the September 2026 auction showed that even a higher-quality lot achieved the lowest value per index point in the disclosed series; biological risk at North Bali remains unresolved; and governance signals — continued lending to a deconsolidated affiliate later impaired, above-formula bonuses in a loss year, and an ASX disclosure query — warrant vigilance from minority holders in a company where the largest shareholder group controls roughly a quarter of the register.

At around 0.74x book and below net tangible assets, the shares already discount a prolonged trough, and modest price recovery would generate disproportionate earnings uplift. We characterise Atlas as a high-risk, asymmetric recovery situation.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedBackground / educationOther current rolesFY2026 total remuneration (AUD)

José Martins

Independent Non-Executive Chairman

Director 17 May 2023; Chairman 1 Jan 2025

25+ years finance executive; former CFO of Alliance Mining Commodities, Macmahon Holdings (ASX) and Ausdrill (now Perenti); Chartered Accountant (South Africa); BAcc (with distinction), University of the Witwatersrand; GAICD

NED, GenusPlus Group (since 2018); NED, Chilwa Minerals (since 20 Oct 2025)

116,632

Timothy (Tim) Martin

Non-Executive Director (non-independent; associated with largest shareholder group)

4 Feb 2013

Executive Chairman of Coogee Chemicals (MD 2012–2015, Exec Chair from Jul 2015); prior packaged-food management; BA, MBA; Harvard OPM (2013); GAICD; former director PACIA and Kwinana Industries Council

None listed

82,800

Cadell Buss

Independent Non-Executive Director

1 Feb 2018

Founder and MD of Chilwa Minerals (ASX: CHW); former CEO of stockbroker DJ Carmichael; former Project and Finance Director, Luso Global Mining; MBA and Master of Project Management (Murdoch University); GAICD

MD, Chilwa Minerals (since 1 Feb 2022)

82,800

Executive Leadership Team

NameTitleSinceBackgroundFY2026 remuneration (AUD)

Michael Ricci

Chief Executive Officer

13 Jun 2022

Prior roles not detailed in retrieved filings

Salary 406,304; STI 55,468; super 60,536; LSL 6,286; share-based 57,154; total 585,748 (FY2025: 562,934)

Jean-Marie Rudd

Chief Financial Officer

4 May 2024

Prior roles not detailed in retrieved filings

Salary 247,191; STI 34,335; super 37,861; LSL 3,760; share-based 7,723; total 330,870 (FY2025: 304,833)

Mat Pullen

Chief Operating Officer (new role)

Appointed during FY2026 (date not specified)

Indonesia-based; over five years in the business

Not a disclosed KMP in FY2026

Susan Park

Company Secretary

19 Dec 2012

25+ years corporate finance/governance; MD of Park Advisory; BCom (UWA), ACA, F Fin, FGIA, FCG, GAICD

Not disclosed separately

Major Shareholders

HolderShares (m)% of 439.0mNotes

Boneyard Investments Pty Ltd

54.9112.5

Tim Martin-associated

Chemco Superannuation Fund Pty Ltd (Chemco Super Fund No 2 A/C)

46.1310.5

Martin-family associated

TJM SF Pty Ltd (TJM Superannuation Fund A/C)

2.030.5

Tim Martin

Tim Martin (direct)

3.680.8—

Tim Martin total relevant interest

106.74

24.3

Per FY2026 AR director interests

HSBC Custody Nominees (Australia)

~28.7

~6.5

Nominee; figure from Motley Fool AU top-20 extract, date not confirmed

Citicorp Nominees

~26.4

~4.1–6.0

Nominee; percentage inconsistent across sources

Abermac Pty Ltd

14.03.2

Simply Wall St (secondary)

Westwood Properties Pty Ltd

8.01.8

Secondary

Morckstow Pty Ltd

8.01.8

Secondary

Tingyao Xu

5.161.2

Secondary

Queensridge Investments Pty Ltd (Gleeson Super Fund A/C)

3.550.8

Secondary

Competitive Landscape

Key Competitors

CompetitorCountrySegment overlapOwnershipRelative positioning vs Atlas

Paspaley Pearling Company

Australia

White South Sea pearls (Broome/NW Australia)

Private

Generally regarded as the world's largest and most prestigious South Sea producer; vertically integrated into luxury retail; higher-end positioning than Atlas

Autore Group

Australia

South Sea pearls and jewellery

Private

Brand-led, jewellery-focused

Cygnet Bay Pearls (Kimberley)

Australia

South Sea pearls, tourism

Private

Small, heritage/tourism niche

Willie Creek Pearls / other Broome producers

Australia

South Sea pearls, retail/tourism

Private

Small producers; retail-tourism mix

Jewelmer

Philippines

Golden South Sea pearls

Private

Dominant in gold-lip pearls; luxury brand integration

Indonesian South Sea producers (numerous, incl. Japanese-affiliated farms)

Indonesia

White/silver/golden South Sea pearls

Private

Same production geography and auction buyer pool; Indonesia is the largest South Sea volume producer by count

Robert Wan / Tahitian producers

French Polynesia

Tahitian (black) pearls

Private

Substitute colour category

Mikimoto

Japan

Akoya and South Sea pearls; luxury retail

Private (K. Mikimoto & Co.)

Brand/retail leader; also a buyer of South Sea pearls

Tasaki & Co.

Japan

Pearls and jewellery

Listing status should be verified

Brand-led jeweller; buyer and own-farm operator

Chinese freshwater pearl producers (Zhuji cluster)

China

Freshwater pearls, including large high-lustre "Edison"-type

Private

Low-cost substitutes improving in size and quality — key long-run threat to smaller South Sea sizes

Hong Kong/Japanese pearl wholesalers

HK/Japan

Downstream

Private

Customers that can also integrate upstream

Competitor Detail

Benchmark (latest fiscal year)Atlas Pearls FY2026

Revenue

A$25.8m

Revenue growth

−42%

EBITDA margin

22% (normalised)

Recent Developments

--

Company Snapshot

1,200

Employees

1987

Founded

Subiaco, Australia

Headquarters

SWOT Analysis

Strengths

  • Stable production base — harvests of 598k (FY2024), 621k (FY2025) and 620k (FY2026) pearls despite biological setbacks (FY2025/FY2026 ARs).
  • Debt-free, liquid balance sheet — borrowings A$38k, cash A$6.9m and undrawn A$2.5m overdraft at 30 Jun 2026; no financial debt since FY2023.
  • Positive cash earnings at the cycle trough — normalised EBITDA A$5.8m (22% margin) even in FY2026.
  • Record seeding in FY2026 — supports harvest volumes in FY2027–FY2028.
  • Multi-channel sales capability — private appointments (e.g. ~A$1.35m in Apr–May 2026) and retention of unsold auction lots for better channels (5,365 pearls retained in Sep 2025).
  • Capital-light growth options — Alyui expansion (7 blocks approved) and 18-month cycle described by management as low-cost, potentially doubling Alyui output.

Weaknesses

  • Declining pearl quality — Quality Index Score down 18% in FY2026 (15% excl. Sumba).
  • Earnings volatility from AASB 141 — biological revaluation swung from +A$13.9m (FY2024) to −A$7.9m (FY2026).
  • Revenue concentration — one customer contributed A$14.3m (~32%) of FY2025 revenue.
  • Thin board and governance bench — three directors; full Board performs remuneration functions; discretionary bonuses paid above formula in a loss year.
  • Operating cash flow collapse — −A$0.09m in FY2026 versus A$16.4m in FY2025.
  • Exposure to a deconsolidated affiliate — continued lending to PT Cahaya Bali (A$3.0m over two years) followed by a A$2.6m impairment.

Opportunities

  • Quality recovery — early FY2027 harvests at Alor and Pungu ~20% above post-2022 average quality index.
  • Production growth — FY30 target of +30–50% capacity; Alyui from ~180k to >400k pearls p.a.
  • Re-seeding — A$1.0–1.5m incremental annual earnings from FY2029 (management estimate).
  • Channel mix uplift — redirecting inventory to value-add wholesale and retail where margins exceed auction.
  • Diversification — lobster pilot and multi-species hatchery licences aligned with Indonesia's Blue Economy Roadmap 2023–2045.
  • Operating leverage on price recovery — FY2024 showed revenue +53% translating to normalised EBITDA +131%.

Threats

  • Biological/environmental events — elevated mortality at North Bali nursery in both FY2025 and FY2026, cause unconfirmed.
  • Luxury-demand downturn — value per index point at A$2.56 in Sep 2026, lowest in the disclosed series.
  • Indonesian regulatory and sovereign risk — licences, permits and transfer-pricing (APA expired 30 Jun 2025, extension pending).
  • FX — FY2026 net FX loss A$1.29m and A$3.4m adverse translation to equity.
  • Climate change — ocean warming and acidification flagged in the risk register and sustainability report.
  • Disclosure/regulatory scrutiny — ASX Aware Letter (Mar 2026) on timeliness of earnings disclosure.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Kobe auction update (April 2025)Share price rose ~10% on release; prices stable at H2 FY2024 levels
9 Apr 2025Tim Martin sells ~17.9m shares (secondary insider data)Largest holder reduces stake; remains ~24% holder
Jun 2025Kobe auction update (June 2025); average $/index point A$4.08Pre-year-end sales performance
11 Aug 20254.4m performance rights granted to executives and senior managers (1.9m to KMP)LTI alignment under new Employee Awards Plan
28 Aug 2025FY2025 Appendix 4E and Annual Report: revenue A$44.3m, normalised EBITDA A$18.6m, cash A$20.2m; FY30 roadmap targeting +30–50% capacityPeak of financial strength entering FY2026
29 Aug 2025Final dividend 1.4c fully franked (total FY2025 2.4c)Payout consistent with 50% policy
19 Sep 2025Notice of AGM releasedRoutine
3 Oct 2025September 2025 Kobe auction: 67,488 pearls sold at A$60 average (~A$4.0m); index 18.04; $/index point A$3.56 (from A$4.08); 5,365 pearls retainedFirst sign of weaker quality and value per index point
23 Oct 2025AGM: remuneration report 92.61% for; Cadell Buss re-elected 99.13%; AGM presentation reiterates strategyGovernance support intact
15 Dec 2025December 2025 Kobe auction: 64,435 pearls at A$80 average; index 30; $/index point A$2.61 (from A$3.50)Higher-quality lot, but value per quality point falls sharply — demand softening
26 Feb 2026H1 FY2026 results: revenue A$12.6m (−30%), net loss A$5.2m; volume +33% to 379k on low-grade sales (53% of units); average price A$33 vs A$63; no interim dividendEarnings downturn crystallises; share price fell ~48% over subsequent period
Early Mar 2026Private sale of pearls ahead of March auction (amount referenced in auction update)Channel diversification in practice
10 Mar 2026Response to ASX Aware Letter regarding timing of disclosure of earnings decline; Company affirms LR 3.1 complianceRegulatory scrutiny of continuous disclosure; share price fell ~20% on day
30 Mar 2026March 2026 Kobe auction: 46,898 pearls sold (one figure in release states 48,898) at A$66 average; index 22; $/index point A$2.95Slight recovery in value per index point
Apr–May 2026~A$1.35m of product sold through private appointmentsPrivate channel contribution
5 Jun 2026June 2026 Kobe auction: 97,423 offered, 76,029 sold (78% sell-through) at A$55 average (~A$4.15m); index 18; $/index point A$3.05Low-quality lot; unsold pearls retained for alternative channels
FY2026 (H2)Sumba trial site mothballed; North Bali oyster transfers suspendedPortfolio rationalisation and biological-risk response
FY2026Mat Pullen appointed Chief Operating OfficerOperational leadership strengthened
FY2026PT Pungu Atlas Indopearls and PT Lembata Atlas Indopearls establishedStructuring for expansion
1 Jul 20269.25m performance rights issued to executives and senior managers (2.0m Ricci, 1.0m Rudd)Further LTI grants after loss year
22 Jul 2026Notification regarding unquoted securitiesAdministrative
26 Aug 2026FY2026 Appendix 4E and Annual Report: revenue A$25.8m (−42%), normalised EBITDA A$5.8m, net loss A$7.9m, cash A$6.9m, undrawn A$2.5m overdraft; record oysters seeded; closing inventory 159k pearls; impairment A$2.6mConfirms cyclical trough; strategy extended to FY32
26 Aug 2026Final dividend 0.45c fully franked (record 1 Sep, paid 25 Sep 2026); AGM key dates announcedDividend maintained at reduced level
27 Aug 2026Shares close down 7.1% at A$0.09 (market cap ~A$41.3m)Market reaction to results
4 Sep 2026September 2026 Kobe auction: 81,176 offered, 50,818 sold at A$75.90 average (~A$3.9m derived); index 29.67; $/index point A$2.56 (from A$3.05)Better quality mix, but value per index point at a cycle low
Sep 2026*Atlas Pearl* vessel scheduled to sail to North Bali after sea trialsLogistics capability addition
Oct 2026 (scheduled)First pearl harvest aboard *Atlas Pearl*Operational milestone
Nov 2026 (scheduled)Next Kobe auction; 2026 AGM (date per 26 Aug 2026 key-dates notice)Next catalysts

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Income Statement: Revenue & Gross Profit: Revenue from contracts with customers rose from AUD 20.6 Mn in FY2022 to AUD 25.8 Mn in FY2026.
Atlas Pearls Ltd — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from contracts with customers20.627.241.744.325.8
Gross profit (S&P Global basis)9.916.333.528.9—
Revenue less farm costs and inventory changes (company P&L basis)———30.514.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.